---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-052908"
form_type: "8-K"
ticker: "BMY"
cik: "0000014272"
company_name: "BRISTOL MYERS SQUIBB CO"
filed_at: "2023-11-13T23:59:59+00:00"
generated_at: "2026-06-08T04:51:24.223506+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Bristol-Myers Squibb completes $4.5B note offering to finance Mirati acquisition

## Summary
- $4.5B note offering completed: $1B 5.75% due 2031, $1B 5.9% due 2033, $1.25B 6.25% due 2053, $1.25B 6.4% due 2063.
- Proceeds to fund general corporate purposes, including the proposed acquisition of Mirati Therapeutics.
- Offering closed November 13, 2023; underwritten by syndicate of banks.

## SEC filing metadata
- accession: 0001140361-23-052908
- form_type: 8-K
- ticker: BMY
- cik: 0000014272
- company_name: BRISTOL MYERS SQUIBB CO
- filed_at: 2023-11-13T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/14272/000114036123052908/0001140361-23-052908-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/14272/000114036123052908/ny20014138x1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-052908
- JSON: https://secwatch.observer/filing/0001140361-23-052908.json
- Plain text: https://secwatch.observer/filing/0001140361-23-052908.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.